128 related articles for article (PubMed ID: 17961421)
21. Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β
Nagatomo Y; McNamara DM; Alexis JD; Cooper LT; Dec GW; Pauly DF; Sheppard R; Starling RC; Tang WH;
J Am Coll Cardiol; 2017 Feb; 69(8):968-977. PubMed ID: 28231950
[TBL] [Abstract][Full Text] [Related]
22. Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.
Fujimura M; Akaike M; Iwase T; Yoshida S; Sumitomo Y; Yagi S; Ikeda Y; Hashizume S; Aihara K; Nishiuchi T; Yasumura Y; Matsumoto T
Acta Cardiol; 2009 Oct; 64(5):589-95. PubMed ID: 20058503
[TBL] [Abstract][Full Text] [Related]
23. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
Castro P; Vukasovic JL; Chiong M; Díaz-Araya G; Alcaino H; Copaja M; Valenzuela R; Greig D; Pérez O; Corbalan R; Lavandero S
Eur J Heart Fail; 2005 Oct; 7(6):1033-9. PubMed ID: 16227141
[TBL] [Abstract][Full Text] [Related]
24. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
Yildirir A; Sade E; Tokgozoglu L; Oto A
Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
[TBL] [Abstract][Full Text] [Related]
25. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
[TBL] [Abstract][Full Text] [Related]
26. [CLINICAL EFFICACY OF THE RECEPTOR BETA AND ALPHA BLOCKERS - CARVEDILOL AND ORNITHINE-ASPARTATE IN PATIENTS WITH CHD AND CHF COMBINED WITH ALCOHOLIC LIVER DISEASE].
Evdokimova AG; Tomova AV; Tereshchenko OI; Zhukolenko LV; Evdokimov VV
Eksp Klin Gastroenterol; 2016; (6):42-7. PubMed ID: 30280552
[TBL] [Abstract][Full Text] [Related]
27. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
28. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
29. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
[TBL] [Abstract][Full Text] [Related]
30. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
31. Effects of cAMP and β-adrenergic receptor antagonists on the function of peripheral T helper lymphocytes in patients with heart failure.
Tian X; Zhang L; Hou Y; Xu W; Dong Y; Liu J; Liang J
Neuroimmunomodulation; 2011; 18(2):73-8. PubMed ID: 20938210
[TBL] [Abstract][Full Text] [Related]
32. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
Massie BM; Nelson JJ; Lukas MA; Greenberg B; Fowler MB; Gilbert EM; Abraham WT; Lottes SR; Franciosa JA;
Am J Cardiol; 2007 May; 99(9):1263-8. PubMed ID: 17478155
[TBL] [Abstract][Full Text] [Related]
33. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.
Akdeniz B; Guneri S; Savas IZ; Aslan O; Baris N; Badak O; Kirimli O; Göldeli O
Int Heart J; 2006 Jul; 47(4):565-73. PubMed ID: 16960411
[TBL] [Abstract][Full Text] [Related]
34. [Autoantibodies against the myocardium beta 1-adrenergic and M2-muscarinic receptors in patients with heart failure].
Zhang L; Hu D; Shi X; Li J; Zeng W; Xu L; Cui L
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):445-7. PubMed ID: 11798611
[TBL] [Abstract][Full Text] [Related]
35. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
36. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
De Vecchis R; Pucciarelli G; Setaro A; Nocerino L
Minerva Cardioangiol; 2000 Nov; 48(11):393-410. PubMed ID: 11214431
[TBL] [Abstract][Full Text] [Related]
37. Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).
Figulla HR; Krzeminska-Pakula M; Wrabec K; Chochola J; Kalmbach C; Fridl P
Int J Cardiol; 2006 Nov; 113(2):153-60. PubMed ID: 16157399
[TBL] [Abstract][Full Text] [Related]
38. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
39. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
40. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
